Spiegel, Jörg
Saarland University
6 papers on CoChatORCID 0000-0002-0527-0144
Most cited papers
- Verified
Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls
Unger, M. M., Spiegel, J., Dillmann, K.-U., Grundmann, D., Philippeit, H., Bürmann, J., Faßbender, K., Schwiertz, A., & Schäfer, K.-H. (2016) · Parkinsonism & Related Disorders
Gut microbiota and healthParkinson's Disease Mechanisms and Treatments
Cited by 1,159
- Verified
Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson's disease
Schwiertz, A., Spiegel, J., Dillmann, U., Grundmann, D., Bürmann, J., Faßbender, K., Schäfer, K.-H., & Unger, M. M. (2018) · Parkinsonism & Related Disorders
Parkinson's Disease Mechanisms and TreatmentsGastrointestinal motility and disorders
Cited by 318
- Verified
Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease
Hochstrasser, H., Bauer, P., Walter, U., Behnke, S., Spiegel, J., Csoti, I., Zeiler, B., Bornemann, A., Pahnke, J., Becker, G., et al. (2004) · Neurology
Parkinson's Disease Mechanisms and TreatmentsNeurological diseases and metabolism
Cited by 111
- Verified
Effects of Resistant Starch on Symptoms, Fecal Markers, and Gut Microbiota in Parkinson’s Disease — The RESISTA-PD Trial
Becker, A., Schmartz, G. P., Gröger, L., Grammes, N., Galata, V., Philippeit, H., Weiland, J., Ludwig, N., Meese, E., Tierling, S., et al. (2022) · Genomics, Proteomics & Bioinformatics
Gut microbiota and healthParkinson's Disease Mechanisms and Treatments
Cited by 102
- Verified
Effects of Resistant Starch on Symptoms, Fecal Markers and Gut Microbiota in Parkinson’s Disease – The RESISTA-PD Trial
Becker, A., Schmartz, G. P., Gröger, L., Grammes, N., Galata, V., Philippeit, H., Weiland, J., Ludwig, N., Meese, E., Tierling, S., et al. (2021) · Genomics Proteomics & Bioinformatics
Gut microbiota and healthParkinson's Disease Mechanisms and Treatments
Cited by 102
- Verified
Functional relevance of ceruloplasmin mutations in Parkinson's Disease
Hochstrasser, H., Tomiuk, J., Walter, U., Behnke, S., Spiegel, J., Krüger, R., Becker, G., Riess, O., & Berg, D. (2005) · The FASEB Journal
Parkinson's Disease Mechanisms and TreatmentsNeurological diseases and metabolism
Cited by 87
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free